These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis. Kim J, Lee SK, Jeong SY, Cho HJ, Park J, Kim TM, Kim S. J Nanobiotechnology; 2021 Nov 17; 19(1):372. PubMed ID: 34789265 [Abstract] [Full Text] [Related]
24. Loss of hepatic Flcn protects against fibrosis and inflammation by activating autophagy pathways. Paquette M, Yan M, Ramírez-Reyes JMJ, El-Houjeiri L, Biondini M, Dufour CR, Jeong H, Pacis A, Giguère V, Estall JL, Siegel PM, Audet-Walsh É, Pause A. Sci Rep; 2021 Oct 28; 11(1):21268. PubMed ID: 34711912 [Abstract] [Full Text] [Related]
25. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH-Future Horizons in NASH Management. Trifylli EM, Kriebardis AG, Koustas E, Papadopoulos N, Deutsch M, Aloizos G, Fortis SP, Papageorgiou EG, Tsagarakis A, Manolakopoulos S. Int J Mol Sci; 2022 Oct 12; 23(20):. PubMed ID: 36293042 [Abstract] [Full Text] [Related]
26. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model. Rein-Fischboeck L, Haberl EM, Pohl R, Schmid V, Feder S, Krautbauer S, Liebisch G, Buechler C. Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May 12; 1863(5):526-537. PubMed ID: 29474931 [Abstract] [Full Text] [Related]
27. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. Nakanishi K, Kaji K, Kitade M, Kubo T, Furukawa M, Saikawa S, Shimozato N, Sato S, Seki K, Kawaratani H, Moriya K, Namisaki T, Yoshiji H. Int J Mol Sci; 2019 Jun 03; 20(11):. PubMed ID: 31163617 [Abstract] [Full Text] [Related]
28. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model. Hayashida M, Hashimoto K, Ishikawa T, Miyamoto Y. Int J Exp Pathol; 2019 Apr 03; 100(2):72-82. PubMed ID: 30887659 [Abstract] [Full Text] [Related]
29. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. Dornas W, Lagente V. Pharmacol Res; 2019 Mar 03; 141():418-428. PubMed ID: 30658094 [Abstract] [Full Text] [Related]
32. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis. Zhu Q, Li H, Ao Z, Xu H, Luo J, Kaurich C, Yang R, Zhu PW, Chen SD, Wang XD, Tang LJ, Li G, Huang OY, Zheng MH, Li HP, Liu F. J Nanobiotechnology; 2022 Jul 27; 20(1):349. PubMed ID: 35897102 [Abstract] [Full Text] [Related]